Latest
-
I Add Two Bargains to My Portfolio
investing One pick, Lazard, is a global investment banking firm. Its reasonable share price provides a margin of safety.
investing -
How One Bad Year Can Wreck Your Investing Results
investing My 2015 setback has had a dramatic impact on my cumulative returns. On that basis, I trail my bogey by 31 percentage points.
investing -
Is Intel's Buying Binge a Good Thing?
investing Intel’s purchase of Mobileye is its second mega-deal in the past two years, but Intel doesn’t have a stellar history when it comes to big acquisitions.
investing -
Can This Fallen Biotech Be Revived?
investing I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.
investing -
A Takeover Boosts My Portfolio
investing But the merger left me sitting on a ton of cash that’s earning almost nothing.
investing -
This Stumbling Biotech Stock Still Has a Lot of Promise
investing Gilead Sciences' robust product pipeline should turn things around.
investing -
My Portfolio's Uninvited Guests
investing A well-considered spin-off can increase the value of both parent and child by allowing each to focus on a narrower set of goals.
investing -
Why Is My Portfolio Lagging? Blame It on 2015
investing A portfolio without FANGs was doomed to have trouble last year.
investing -
Learning From My Misguided Attempt to Beat the Market
Investor Psychology Selling quality stocks was just one of the mistakes.
Investor Psychology
